Therapeutic potential of monoclonal antibodies to the leucocyte common antigen.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Advances in Experimental Medicine and Biology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/978-1-4613-2463-8_97PMID 2931962
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunohistological screening in the selection of monoclonal antibodies: the use of isotype-specific antiglobulins.

  1984cited by this paper
• Therapeutic potential of monovalent monoclonal antibodies

  1984cited by this paper
• A Common Epitope Identified by a Monoclonal Antibody, MID 2, Present on All Leucocytes and Associated with a Group of High Molecular Weight Glycopeptides

  1984cited by this paper
• Cytolysis of nucleated cells by complement: inhibition of membrane-transmethylation enhances cell death by C5b-9.

  1984cited by this paper
• Removal of T cells from bone marrow for transplantation: a monoclonal antilymphocyte antibody that fixes human complement.

  1983cited by this paper
• The mechanism of synergistic complement‐mediated lysis of rat red cells by monoclonal IgG antibodies

  1983cited by this paper
• The Lyt‐2, Lyt‐3 Macromolecules: Structural and Functional Studies

  1982cited by this paper
• Univalent antibodies kill tumour cells in vitro and in vivo

  1982cited by this paper
• Monoclonal Antibodies Specific for Rat IgG1, IgG2a, and IgG2b Subclasses, and Kappa Chain Monotypic and Allotypic Determinants: Reagents for Use with Rat Monoclonal Antibodies

  1982cited by this paper
• Identification with a monoclonal antibody of a predominantly B lymphocyte-specific determinant of the human leukocyte common antigen. Evidence for structural and possible functional diversity of the human leukocyte common molecule

  1981cited by this paper
• A rapid solid-phase enzyme-linked binding assay for screening monoclonal antibodies to cell surface antigens.

  1981cited by this paper
• Anti‐D‐coated Rh‐positive red cells will bind the first component of the complement pathway, C1q

  1981cited by this paper
• Differences in the ability of rat IgG subclasses to consume complement in homologous and heterologous serum

  1980cited by this paper
• Monoclonal antibody to a human leukocyte‐specific membrane glycoprotein probably homologous to the leukocyte‐common (L‐C) antigen of the rat

  1980cited by this paper
• Immunosuppressive properties of rabbit antibodies against a major glycoprotein restricted to rat leukocyte membranes.

  1980cited by this paper
• Rat × rat hybrid myelomas and a monoclonal anti-Fd portion of mouse IgG

  1979cited by this paper
• Purification with monoclonal antibody of a predominant leukocyte‐common antigen and glycoprotein from rat thymocytes

  1979cited by this paper
• Glycoproteins and antigens of membranes prepared from rat thymocytes after lysis by shearing or with the detergent Tween-40.

  1978cited by this paper
• Synergistic cytotoxic effects of antibodies directed against different cell surface determinants.

  1978cited by this paper
• Interspecies spleen-myeloma hybrid producing monoclonal antibodies against mouse lymphocyte surface glycoprotein, T200

  1978cited by this paper
• The effect of antigen on antibodies: recent studies.

  1978cited by this paper
• QUANTITATIVE SEROLOGICAL ANALYSIS OF A RABBIT ANTI‐RAT LYMPHOCYTE SERUM AND PRELIMINARY BIOCHEMICAL CHARACTERISATION OF THE MAJOR ANTIGEN RECOGNISED

  1977cited by this paper
• Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A.

  1975cited by this paper
• Some Aspects of Normal and Abnormal Cell Surface Genetics

  1969cited by this paper
• Complement Fixation on Cell Surfaces by 19S and 7S Antibodies

  1965cited by this paper

• Historical perspective and a glance into the antibody-based conditioning regimens: A new era in the horizon?

  2021cites this paper
• Progress toward antibody-induced transplantation tolerance.

  2007cites this paper
• The clinical application of monoclonal antibody therapies in renal transplantation

  2004cites this paper
• Therapeutic advances in immunosuppression

  1994cites this paper
• Pretreatment of kidney allografts with monoclonal antibodies to CD 45: results of a multicentre study

  1994cites this paper
• Synthesis and functional characterization of a recombinant monoclonal antibody directed against the alpha-chain of the human interleukin-2 receptor.

  1991cites this paper
• Combinations of anti-transferrin receptor monoclonal antibodies inhibit human tumor cell growth in vitro and in vivo: evidence for synergistic antiproliferative effects.

  1990cites this paper
• Effect of graft perfusion with two CD45 monoclonal antibodies on incidence of kidney allograft rejection.

  1989cites this paper
• CD4 monoclonal antibody pairs for immunosuppression and tolerance induction

  1987cites this paper
• Human Complement-Fixing Antibodies in Transplantation

  1985cites this paper